Le Lézard
Classified in: Health
Subject: NEW PRODUCTS/SERVICES

Imprivata expands its integrated digital identity platform to defragment identities across disparate applications


WALTHAM, Mass., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Imprivata, the digital identity company for mission- and life-critical industries, today announced the expansion of its integrated digital identity platform to defragment identities across a broad set of clinical and enterprise applications, with full visibility into individual user access activity. This integration leverages Imprivata OneSign, the company's single sign-on solution as the identity source for Imprivata FairWarning, its risk analytics and intelligence offering, to uniquely provide the necessary view of users across the entire application ecosystem to ensure compliance and reduce security risks.

Healthcare organizations must understand quickly and easily who is accessing protected health information (PHI) to accurately detect, investigate, and prevent major issues before they happen. However, an alarming 51% of organizations don't monitor access to critical systems and data. For most, it is difficult to understand anomalous behavior across the network as user IDs are not consistent across applications. As a result, it can be extremely challenging to remain compliant with HIPAA and other regulations while preventing hacks and data breaches.

"Today's security, compliance, and privacy professionals are facing unprecedented complexities that create barriers to delivering efficient and seamless access to technology resources needed for optimum patient care delivery," said Mark McArdle, Chief Products and Design Officer at Imprivata. "Solving complex digital identity challenges is our key priority, so we're proud to extend our platform of capabilities to make their jobs easier and their organizations more secure."

Available immediately, this integration enables healthcare organizations to:

Imprivata FairWarning and Imprivata OneSign contribute broadly to the Imprivata Digital Identity Framework (DIF), a guide to enabling, controlling, and monitoring identities across highly complex ecosystems.

For more information, visit www.imprivata.com.

About Imprivata
Imprivata is the digital identity company for mission- and life-critical industries, redefining how organizations solve complex workflow, security, and compliance challenges with solutions that protect critical data and applications without workflow disruption. Its platform of interoperable identity, authentication, and access management solutions enable organizations in over 45 countries to fully manage and secure all enterprise and third-party digital identities by establishing trust between people, technology, and information.

Media Contact 
Christy Sievert 
Red Lorry Yellow Lorry 
imprivata@rlyl.com  
857 217 2886 



These press releases may also interest you

at 16:40
Today, Family Research Council, along with a coalition of thirteen other pro-life organizations, sent a letter addressed to the leadership of Walmart Inc. calling on them not to seek certification to dispense chemical abortion drugs, as well as a...

at 16:30
In response to severe weather in Texas, Blue Cross Blue Shield of Massachusetts (Blue Cross) is expediting access to care for members who may be affected.  ...

at 16:10
Gilead Sciences, Inc. announced today that its executives will be speaking at the following investor conferences: SVB Securities Global Biopharma Conference on Tuesday, February 14 at 11:20 AM Eastern Time Cowen Annual Health Care Conference on...

at 16:10
Horizon Therapeutics plc : RECOMMENDED CASH OFFER for HORIZON THERAPEUTICS PLC by Pillartree Limited, a newly formed private limited company wholly owned by Amgen Inc. to be implemented by way of a scheme of arrangement under Chapter 1 of Part...

at 16:10
Junior R. King, DPM, is being recognized by Continental Who's Who as a Distinguished Healthcare Provider for his contributions to the medical field. Dr. King graduated with a medical degree from the Temple University School of Podiatric Medicine, a...

at 16:05
Bright Minds Biosciences Inc. ("Bright Minds" or the "Company") announces that it has received a notification letter (the "Notification Letter") from the Nasdaq Stock Market LLC ("NASDAQ") dated January 26, 2023, notifying the Company that due to...



News published on 17 october 2022 at 09:05 and distributed by: